Netherlands

This page shows the risk assessment for the Netherlands

Time series for The Netherlands are presented below.  The plot on the left gives the incidence per million people and has been normalized with the 1980 figure. On the right the excess incidence is shown per million people relative to the 1980 level. Although the UV-dose is expected to have returned to the 1980 level by 2050, the skin cancer incidence rates peak in 2040 (SCC) and 2065 (BCC and CMM) respectively. A delay between dose and incidence is what we expect: people get ill from a dose received in the past; skin cancer takes some time to develop after reception of the hazardous dose. For BCC and for CMM the model has a stronger weighting of the UV-dose received in the youth than later in life. For SCC the dose of each year is uniformly weighted.

rel excess 436pix

RIVM Committed to health and sustainability
Menu